Cow urine has been granted US Patents (No. 6,896,907 and 6,410,059) for its medicinal properties, particularly as a bioenhancer and as an antibiotic, antifungal and anticancer agent. With regard to the latter, it has been observed to increase the potency of “Taxol” (paclitaxel) against MCF-7, a human breast cancer cell line, in in vitro assays (US Patent No. 6,410,059).
These milestone achievements highlight the potential role of cow urine in treatment of bacterial infections and cancer, and demonstrate that cow urine can enhance the efficacy and potency of other drugs.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117312/#:~:text=Cow%20urine%20has%20been%20granted,antibiotic%2C%20antifungal%20and%20anticancer%20agent.
No comments:
Post a Comment